Geron Corp. (GERN)

1.72 -0.23 (-11.79%) USD  |  NASDAQ  |  Feb 25, 16:00
1.70 -0.02 (-1.16%) After-Hours: 20:00
More

Geron Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for GERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Plus Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
SELLAS Life Sciences Group, Inc. --
Rezolute, Inc. --
GT Biopharma, Inc. --